Skip to content

Photodynamic Bone Stabilization Procedure Pack USSL-1700220Recalls & reported problems

Illuminoss Medical, Inc. · Photodynamic Bone Stabilization Procedure Pack · Class 2 · Implant

All models of Photodynamic Bone Stabilization Procedure Pack (11)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M986USSL17002200), received between Oct 12, 2022 and Oct 11, 2024 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Fracture1
  • Insufficient Device Problem Information1
  • Material Too Soft/Flexible1

Patient problems

  • Implant Pain1
  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1
  • Post Operative Wound Infection1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 11, 2024Insufficient Device Problem Information; Material Too Soft/Flexible; Insufficient Device Problem Information; Material Too Soft/Flexible

    THE REP STATED THAT WHEN THE SURGEON TRIED TO INFUSE THE IMPLANT WITH MONOMER, HE WAS UNABLE TO APPLY PRESSURE TO THE SYRINGE HANDLE AND COULD NOT GET ANY MONOMER INTO THE BALLOON. ACCORDING TO THE REP, THE PREPPED IMPLANT HAD NOT BEEN EXPOSED TO LIGHT AT ANY POINT. THEY THEN REMOVED THE IMPLANT FROM THE CANAL AND USED A NEW ONE. THE SECOND IMPLANT WAS PREPPED USING THE MONOMER SYRINGE FROM THE FIRST ATTEMPT, BUT WHEN TRYING TO APPLY THE MONOMER, THE SURGEON STATED THAT THE SYRINGE WAS CURING AND AGAIN COULD NOT INFUSE THE BALLOON. THE SECOND IMPLANT WAS REMOVED AND DISCARDED. THEY THEN TRIED A THIRD BALLOON FROM A NEW IMPLANT KIT, WHICH WAS SUCCESSFUL WITH NO ISSUES.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 20428767 ↗
  • InjuryApr 24, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AN ADVERSE EVENT WAS ENTERED INTO THE ILLUMINOSS CLINICAL STUDY REGISTRY ON MARCH 26, 2024 FOR AN EVENT WHICH STARTED ON MAY 31, 2022. A 75 YEAR OLD FEMALE EXPERIENCED A TRAUMATIC FALL AND LEFT FEMUR FRACTURE WHICH WAS TREATED WITH ONE 17X280MM ILLUMINOSS IMPLANT AND A PLATE WITH 8 SCREWS. ABOUT A MONTH AND HALF AFTER THE INDEX PROCEDURE, THE PATIENT EXPERIENCED AN INFECTION AND A DEHISCENCE WOUND ON THE LEFT MEDIAL WOUND, LIKELY WITH A DRAINING SINUS TUNNEL.

    Patient problems: Post Operative Wound Infection

    MAUDE report 19176939 ↗
  • InjuryOct 12, 2022Fracture; Fracture

    AN ADVERSE EVENT WAS ENTERED INTO THE ILLUMINOSS CLINICAL STUDY REGISTRY ON (B)(6) 2022 FOR AN EVENT WHICH OCCURRED ON (B)(6) 2019. A 59 Y/O FEMALE PATIENT WAS TREATED ON (B)(6) 2018 WITH ILLUMINOSS IMPLANT FOR A PATHOLOGICAL FRACTURE OF THE RIGHT HUMERUS. THE PATIENT EXPERIENCED PAIN AT THE TREATED SITE OVER THE COURSE OF FOLLOW-UP VISITS, AND 296 DAYS POST IMPLANTATION ON (B)(6) 2019 THE PATIENT RECEIVED SURGICAL INTERVENTION TO EXPLANT THE ILLUMINOSS IMPLANT, RESECT THE CENTRAL SEGMENT OF TUMOR FROM THE MID HUMERUS, AND RECONSTRUCT IT WITH A CEMENTED INTERCALARY METAL REPLACEMENT TO ACHIEVE STABILIZATION OF THE ORIGINAL BONE FRACTURE.

    Patient problems: Implant Pain

    MAUDE report 15591383 ↗

Other Rod, Fixation, Intramedullary And Accessories, In-Vivo Cured, Light-Activated devices

All Rod, Fixation, Intramedullary And Accessories, In-Vivo Cured, Light-Activated devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page